Based on enhanced binding of PriB variant Q45A to FITC-DnaT in the absence of ssDNA, we expected that DnaT would have a greater ability to compete with ssDNA for binding to PriB:Q45A compared to wild type PriB. However, PriB:Q45A shows wild type levels of competition between fluoro-ssDNA and DnaT and has a K d,app of 352.2 +/-54.4 nM ( Figure 3B and Table 1 ). One possible explanation is that the PriB Q45A variant presents a surface to DnaT that bears resemblance to ssDNA-bound PriB at this region of the protein.
Since the residues on the surface of PriB analogous to the homotetramerization surface of SSB do not seem to play a role in PriA, DnaT, or ssDNA binding, what function do they confer? One possibility is that they serve as a binding platform for heterologous proteins other than PriA or DnaT. At least one other protein, SSB, has been reported to physically interact with PriB (Low et al., 1982) , and there may be others awaiting discovery. While no other binding partners were identified for PriB in a recent, genome-wide tandem-affinity-purification study (Butland et al., 2005) , our results indicate that protein:protein interactions involving PriB can be largely DNA-dependent and might not be observed under conditions that could remove DNA from nucleoprotein complexes. A second possible function for these residues, given that priB is thought to have arisen by gene duplication of ssb (Ponomarev et al., 2003) , is that they have been selected for over time because they destabilized homotetramerization of the product of the ancestral priB gene, giving rise to a stable PriB homodimer that was subsequently adapted for a new role in the cell. If this were the case, one would expect that mutation of these residues to create a SSB-like surface could promote formation of a PriB homotetramer and disrupt PriB function in replication restart pathways. Clearly, further investigation will be required to unravel the functional role of this surface of PriB.
Supplemental Experimental Procedures
Cloning priA variants, priB variants, and dnaT. E. coli priA variants were amplified from strain K12 genomic DNA by polymerase chain reaction (PCR) using oligonucleotide primers oML100 and oML101 (intact priA), oML100 and oML141 (priA DBD), and oML101 and oML143 (priA HD) (Supplementary Table   1 ). The PCR-amplified products were individually cloned into the pET28b expression vector (Novagen) using NdeI and BamHI restriction sites. The priA:K230A variant was constructed using the Stratagene Quikchange sitedirected mutagenesis kit using oligonucleotide primers oML221 and oML222
(Supplementary Table 1) as previously described (Lopper et al., 2004) . The resulting plasmids, pML100 (intact priA), pML118 (priA DBD), pML120 (priA HD), and pML152 (priA:K230A) encode priA variants with a 5' six-Histidine tag and thrombin cleavage site. The priB gene of E. coli was cloned as previously described (Lopper et al., 2004) . Variants of priB were constructed using the Stratagene Quikchange site-directed mutagenesis kit using appropriate oligonucleotide primers (Supplementary Table 1) as previously described (Lopper et al., 2004) . The dnaT gene of E. coli was amplified from strain K12 genomic DNA by PCR using oligonucleotide primers oML106 and oML107 (Supplementary Table 1 ). The PCR-amplified product was cloned into pET28b using NdeI and BamHI restriction sites. The resulting plasmid, pML103, encodes dnaT with a 5' six-Histidine tag and thrombin cleavage site. PriA DBD was purified from cultures of BL21(DE3) E. coli harboring plasmid pML118 grown at 37°C in LB medium supplemented with 50 ug·mL -1 kanamycin.
Over-expression of priA DBD was induced with 1 mM IPTG and cells were harvested after 4 hours of growth at 37°C by centrifugation at 5,000 x g. Cells were lysed in 10 mM Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 0.1 M glucose,
Lysates were clarified by centrifugation at 26,000 x g and His-tagged PriA DBD was bound to nickel-NTA agarose. The nickel-NTA agarose beads were washed with lysis buffer and bound proteins were eluted in 10 mM Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 250 mM imidazole, 1 mM β-mercaptoethanol. PriA DBD was further purified through a Sephacryl S-300 size exclusion column in 10 mM
Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 1 mM β-mercaptoethanol. PriA DBD fractions were pooled, concentrated to approximately 10 g·L -1 , and stored at -80°C.
PriA HD was purified from cultures of BL21(DE3) E. coli harboring plasmid pML120 grown at 37°C in LB medium supplemented with 50 ug·mL -1 kanamycin.
Over-expression of priA HD was induced with 0.5 mM IPTG and cells were harvested after 4 hours of growth at 37°C by centrifugation at 5,000 x g. Cells were lysed in 10 mM Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 0.1 M glucose, 10 mM imidazole, 1 mM β-mercaptoethanol, 1 mM PMSF by sonication on ice.
Lysates were clarified by centrifugation at 26,000 x g and His-tagged PriA HD was bound to nickel-NTA agarose. The nickel-NTA agarose beads were washed with lysis buffer and bound proteins were eluted in 10 mM Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 250 mM imidazole, 1 mM β-mercaptoethanol. PriA HD was further purified through a Sephacryl S-300 size exclusion column in 10 mM Hepes pH 7, 10% (v/v) glycerol, 0.5 M NaCl, 1 mM β-mercaptoethanol. PriA HD fractions were pooled, concentrated to approximately 1 g·L -1 , and stored at -80°C.
Purification of PriB variants was as previously described (Lopper et al., 2004) .
DnaT was purified from cultures of BL21(DE3) E. coli harboring plasmid pML103 grown at 37°C in LB medium supplemented with 50 ug·mL -1 kanamycin. Overexpression of dnaT was induced with 0.5 mM IPTG and cells were harvested after 4 hours of growth at 37°C by centrifugation at 5,000 x g. Cells were lysed in 10 mM Tris·HCl pH 8.5, 10% (v/v) glycerol, 6 M guanidine·HCl, 250 mM NaCl, 1 mM β-mercaptoethanol by sonication on ice and lysates were clarified by centrifugation at 26,000 x g. His-tagged DnaT was bound to nickel-NTA agarose. from Integrated DNA Technologies, Inc. and were annealed to create the forked DNA substrate as previously described (Heller and Marians, 2005) .
Limited proteolysis. Purified PriA (1.3 µM) was incubated with 0.5 µM PhiX174 virion ssDNA in 10 mM Tris-HCl pH 8, 33 mM NaCl, 1 mM EDTA for 10 minutes on ice. Trypsin (0.013 µM) was added and the reactions were incubated at room temperature for 2, 10, or 20 minutes. Reactions were stopped by addition of SDS-PAGE sample buffer and the products were resolved through a 12.5%
polyacrylamide gel and visualized with Coomassie Brilliant Blue.
DnaB loading assay.
Reactions were performed as previously described (Heller and Marians, 2005) except that 13 nM PriA:K230A and 60 nM DnaT variants were used.
Structure determination of PriB:E39A. Crystallization of PriB:E39A was performed as previously described for wild type PriB (Lopper et al., 2004) . The crystal structure of PriB:E39A was solved to 2.25 Å resolution by molecular replacement with the program Amore (Navaza, 1994) Table 2 ).
Plasmid complementation assay. Plasmid complementation assays with priB
variants were performed as previously described (Boonsombat et al., 2006) . 
where Ιj is the intensity measurement for reflection j and <Ι> is the mean intensity for multiply recorded reflections. ** R work/free = Σ|| F obs | -| F calc || / | F obs | , where the working and free R factors are calculated using the working and free reflection sets, respectively. The free reflections (5% of the total) were held aside throughout refinement. 
